Clinical trial

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

NCT02316327

Study summary

ClinicalTrials.gov

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention gemcitabine, cisplatin and bevacizumab Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE4

Conditions

Non-Small Cell Lung Cancer (NSCLC)unresolved

Interventions

gemcitabine, cisplatin and bevacizumabDRUG

Sponsors & collaborators

Fundacion Clinic per a la Recerca Biomédicalead sponsor

Mapped research locations

BarcelonaBarcelona, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02316327 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.